• Home
  • NEW DAY MEDICINE
  • 8 (82) 2025
  • 14 -8 (82) 2025 - Pulatova M.B., Badritdinova M.N. - ANALYSIS OF TRENDS IN THE PREVALENCE OF RISK FACTORS CHARACTERISTIC OF COMPLEX METABOLISM DISORDERS

14 -8 (82) 2025 - Pulatova M.B., Badritdinova M.N. - ANALYSIS OF TRENDS IN THE PREVALENCE OF RISK FACTORS CHARACTERISTIC OF COMPLEX METABOLISM DISORDERS

ANALYSIS OF TRENDS IN THE PREVALENCE OF RISK FACTORS CHARACTERISTIC OF COMPLEX METABOLISM DISORDERS

Pulatova M.B. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Badritdinova M.N. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The prevalence of the considered components of metabolic syndrome in the studied population is much higher, and the prevalence of metabolic syndrome and its components increases with age. The most intensive growth of metabolic syndrome and its components is observed after 40 years, the dynamics of the distribution of individual components of MS is uncertain

Key words: Arterial hypertension, obesity, hyperlipidemia, diabetes mellitus

First page

74

Last page

77

For citation:Pulatova M.B., Badritdinova M.N. - ANALYSIS OF TRENDS IN THE PREVALENCE OF RISK FACTORS CHARACTERISTIC OF COMPLEX METABOLISM DISORDERS//New Day in Medicine 8(82)2025 74-77 https://newdayworldmedicine.com/en/new_day_medicine/8-82-2025

List of References

  1. Абдухакимова Н.А. Особенности клинического течения подагры при метаболическом синдроме // канд. дисс. Ташкент, 2011. С. 152.
  2. Акбарова М., Мамасолиев Н.С. Эпидемиологические, клинико-биоритмологические и профилактические аспекты хронической сердечной недостаточности в условиях резко континентального климата Ферганской долины/V-конгресса кардиологов стран СНГ в журнале Кардиология СНГ. 2005 т.-3, № 2 ст. 17.
  3. Шагазатова Б.Х., Оценка качества амбулаторно-поликлинического наблюдения за больными сахарным диабетом // Врачебное дело, 2013.
  4. American Diabetes Association. Prevention or delay of type 2 diabetes. Diabetes Care. 2017;40 (Suppl 1): S44–S47.
  5. Aspry KE, Van Horn L, Carson JAS, et al.: Medical Nutrition Education, Training, and Competencies to Advance Guideline-Based Diet Counseling by Physicians: A Science Advisory from the American Heart Association. Circulation. 2018;137(23): e821–e841. 10.1161/CIR.0000000000000563.
  6. Barrett-Connor E, Khaw KT. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol 1988; 128:116–23. 10.1093/oxfordjournals.aje.a114934
  7. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365(9467):1333–46.
  8. Frd, E. S., Giles, W. H. & Dietz, W. H. Prevalence the metabоlic syndrоme amng US adults: findings frm the third Natinal Health and Nutritin Examinatin Survey. JAMA 287, 356–359 (2002).
  9. Teixeira TF, Alves RD, Moreira AP, Peluzio Mdo C. Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes. Nutr Rev. 2015; 73:175–190.
  10. Zinman B, Wanner C, Lachin JM, et al; EMPAREG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015; 373:2117–2128.

    file

    download